Home sankyo
 

Keywords :   


Tag: sankyo

Daiichi Sankyo and ArQule Announce Top-Line Results of Phase 2 Trial...

2013-01-12 04:25:40| Biotech - Topix.net

Daiichi Sankyo Company, Limited and ArQule, Inc. today announced the top-line results of a randomized Phase 2 signal generation trial of tivantinib used in combination with irinotecan and cetuximab in patients with refractory or relapsed colorectal cancer .

Tags: results trial phase announce

 

Sites : [1] [2]